1. ScholarBank@NUS

Boon Cher Goh

rp04505

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Boon Cher Goh
Variants
Goh, Boon Cher
Goh B.C.
Goh, B.C.
Goh, B.-C.
 
Main Affiliation
 
Faculty
 
Email
phcgbc@nus.edu.sg
 
Other emails
 

Publications

Results 1-17 of 17 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
118-Jan-2021Tiny mirnas play a big role in the treatment of breast cancer metastasisTeo, Andrea York Tiang; Xiang, Xiaoqiang; Le, Minh T. N. ; Wong, Andrea Li-Ann ; Zeng, Qi ; Wang, Lingzhi ; Goh, Boon-Cher 
22018Third generation EGFR TKIs: Current data and future directionsTan, C.-S; Kumarakulasinghe, N.B; Huang, Y.-Q; Ang, Y.L.E; Choo, J.R.-E; Goh, B.-C ; Soo, R.A 
32019Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumorsLee M.; Hirpara J.L. ; Eu J.-Q. ; Sethi G. ; Wang L. ; Goh B.-C. ; Wong A.L. 
41-Mar-2020Targeting mitochondrial apoptosis to overcome treatment resistance in cancerNgoi N.Y.L.; Choong C.; Lee J.; Bellot G. ; Wong A.L.A. ; Goh B.C. ; Pervaiz S. 
520-Oct-2020Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapyLi, J.; Eu, J.Q. ; Kong, L.R. ; Wang, L. ; Lim, Y.C. ; Goh, B.C. ; Wong, A.L.A. 
631-Dec-2021Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?Ma, Z; Woon, CYN; Liu, CG; Cheng, JT; You, M; Sethi, G ; Wong, ALA ; Ho, PCL ; Zhang, D; Ong, P; Wang, L ; Goh, BC 
71-Jan-2021Putting the BRK on breast cancer: From molecular target to therapeuticsAng, Hui Li; Yuan, Yi ; Lai, Xianning ; Tan, Tuan Zea ; Wang, Lingzhi ; Huang, Benjamin BoJun; Pandey, Vijay; Huang, Ruby Yun-Ju; Lobie, Peter E ; Goh, Boon Cher ; Sethi, Gautam ; Yap, Celestial T ; Chan, Ching Wan ; Lee, Soo Chin ; Kumar, Alan Prem 
82019Population diversity in oncology drug responses and implications to drug developmentWalsh, R.; Goh, B.-C. 
92005Novel agents that potentially inhibit irinotecan-induced diarrheaYang, X. ; Hu, Z.; Chan, S.Y. ; Chan, E. ; Goh, B.C. ; Duan, W.; Zhou, S. 
102005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Goh, B.C. ; Chan, E. ; Duan, W. ; Huang, M.; McLeod, H.L.
11Dec-2017'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signallingOng, Mei S; Cai, Wanpei ; Yuan, Yi; Leong, Hin C ; Tan, Tuan Z ; Mohammad, Asad; You, Ming L; Arfuso, Frank; Goh, Boon C ; Warrier, Sudha; Sethi, Gautam ; Tolwinski, Nicholas S; Lobie, Peter E ; Yap, Celestial T ; Hooi, Shing C ; Huang, Ruby Y ; Kumar, Alan P 
1213-Jun-2016Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive reviewNicholas Li-Xun Syn; Wei-Peng Yong ; Boon-Cher Goh ; Soo-Chin Lee 
1317-Jul-2017Do STAT3 inhibitors have potential in the future for cancer therapy?Andrea Wong; Gautam Sethi ; Boon-Cher Goh ; Hirpara J.L. ; Pervaiz S. ; Eu J.Q. 
14Sep-2000Design of phase I and II clinical trials in oncology and ethical issues involvedGoh, B.C. 
15Sep-2013Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelinesD'Cruz, A.; Lin, T.; Anand, A.K.; Atmakusuma, D.; Calaguas, M.J.; Chitapanarux, I.; Cho, B.C.; Goh, B.C. ; Guo, Y.; Hsieh, W.S.; Hu, C.; Kwong, D.; Lin, J.C.; Lou, P.J.; Lu, T.; Prabhash, K.; Sriuranpong, V.; Tang, P.; Vu, V.V.; Wahid, I.; Ang, K.K.; Chan, A.T.
162016Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentWang, L ; Khoa Phan, D.D; Zhang, J; Ong, P.-S ; Thuya, W.L ; Soo, R.A ; Wong, A.L.-A ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
172018A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugsWong, A.L.-A ; Xiang, X; Ong, P.S ; Mitchell, E.Q.Y; Syn, N; Wee, I; Kumar, A.P ; Yong, W.P ; Sethi, G ; Goh, B.C ; Ho, P.C.-L ; Wang, L